Bafna Pharmaceuticals Revenue

Bafna Pharmaceuticals had revenue of 331.88M INR in the quarter ending December 31, 2024, with 16.68% growth. This brings the company's revenue in the last twelve months to 1.48B, down -3.34% year-over-year. In the fiscal year ending March 31, 2024, Bafna Pharmaceuticals had annual revenue of 1.52B with 32.18% growth.

Revenue (ttm)

1.48B

Revenue Growth

-3.34%

P/S Ratio

1.15

Revenue / Employee

4.08M

Employees

363

Market Cap

1.70B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	1.52B	371.16M	32.18%
Mar 31, 2023	1.15B	302.10M	35.48%
Mar 31, 2022	851.40M	139.22M	19.55%
Mar 31, 2021	712.18M	287.45M	67.68%
Mar 31, 2020	424.73M	-11.67M	-2.67%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	516.03B
Divi's Laboratories	90.78B
Cipla	267.20B
Apollo Hospitals Enterprise	211.46B
Mankind Pharma	116.41B
Zydus Lifesciences	222.47B
Aurobindo Pharma	309.22B
Alkem Laboratories	127.57B

Revenue Rankings